COVID-19 pandemic response
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe. Our buildings are open for lab-based research work.
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
New Online Event
Innovations in phenotyping for Obesity, Diabetes and Co-morbidities. 6 July 2021
Congratulations to Professor Fiona Gribble, Deputy Director of the IMS-MRL and Director of Graduate Education for the Cambridge University School of Clinical Medicine, who…
Research published today in Nature Communications Biology shows how women who will develop potentially life-threatening disorders during pregnancy can be identified early when hormone levels…
New research published today in Nature Medicine has found that one in every 340 people might carry a mutation in a single gene that…
Congratulations to Maša Josipović, PhD student from Mark Evans’ group, who is the joint recipient of the 2021 Bill Gates Senior Prize. The award,…